Goldman Sachs raises Boston Scientific stock price target to $124 on growth outlook
PositiveFinancial Markets

Goldman Sachs has raised its price target for Boston Scientific's stock to $124, reflecting a strong growth outlook for the company. This adjustment indicates confidence in Boston Scientific's future performance, which could attract more investors and positively impact the stock market. Such moves are significant as they can influence trading patterns and investor sentiment, highlighting the company's potential in the medical device sector.
— Curated by the World Pulse Now AI Editorial System